Trials / Completed
CompletedNCT02414581
Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%
Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% to Reduce the Rate Oral Colonization by Gram-negative Bacteria in Patients With Chemotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Hospital Regional de Alta Especialidad del Bajio · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical triple-blind randomized controlled trial to assess the use of two different mouthwashes to reduce the oral colonization by gramnegative bacteria in patients with chemotherapy
Detailed description
Clinical triple-blind randomized controlled trial. With two arms to the study: 1. Mouth rinses with chlorhexidine-based solution at a concentration of 0.12%, using as a vehicle to 7% ethyl alcohol. 2. Mouthwashes with solution based only 7% ethyl alcohol. GOAL. Assess whether there decrease in the rate of oral colonization by gram-negative bacteria in patients with chemotherapy by using chlorhexidine mouthwash. SPECIFIC OBJECTIVES: 1. The rate of the oral colonization by gram-negative bacteria initiation of chemotherapy. 2. The rate of oral colonization by gram-negative bacteria after 10 days of initiation of chemotherapy. 3. Identify microbiologically gram-negative bacteria colonizing the oral cavity. SECONDARY OBJECTIVES 1\. The presence of severe neutropenia and fever in each study group during the first 10 days of starting treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | chlorhexidine 0.12%/Ethyl alcohol 7% | Mouth rinses with chlorhexidine 0.12%-based solution |
| DRUG | Ethyl Alcohol 7% | Mouth rinses with Ethyl Alcohol 7%-based solution |
| DRUG | Chlorhexidine 2%/Ethyl alcohol 7% | Mouth rinses with chlorhexidine 2%-based solution |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-08-01
- Completion
- 2016-09-01
- First posted
- 2015-04-10
- Last updated
- 2018-05-25
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT02414581. Inclusion in this directory is not an endorsement.